[ad_1]
The Cigna Group (NYSE:CI) is included among the many 11 Defensive Healthcare Dividend Shares to Purchase Now.
Picture by Alexsander-777 from Pixabay
The Cigna Group (NYSE:CI) is an American multinational firm that professionalvides managed healthcare and that insurance providers.
On October 14, Goldman Sachs analyst Scott Fidel initiated protection of The Cigna Group (NYSE:CI) with a Purchase score and a value goal of $370. In his observe, he acknowledged that the managed care sector is experiencing its steepest underwriting downturn in greater than 15 years. Goldman Sachs recommends better publicity to Medicare Benefit, anticipating a margin restoration section starting in 2026, though it expects that rebound to range throughout the trade. The agency additionally projects a slower restoration for Medicaid and the healthcare trade markets.
The Cigna Group (NYSE:CI) has additionally drawn investor curiosity after Wells Fargo raised its price target on the stock to $354 from $340 on October 7 whereas sustaining an Equal Weight score. The agency made this adjustment as a part of its up to date outlook for the sector forward of Q3 2025 earnings, noting that the extension of improved subsidies now appears more probin a position.
The Cigna Group (NYSE:CI) proceeds to enchantment to income-focused investors as properly, with the corporate having raised its dividend for 5 consecutive years. It at present affords a quarterly dividend of $1.51 per share and has a dividend yield of two.00%, as of October 14.
Whereas we acknowledge the potential of CI as an funding, we consider sure AI shares supply better upside potential and carry much less draw back threat. If you happen to’re searching for an especially undervalued AI inventory that additionally stands to learn considerably from Trump-era tariffs and the onshoring development, see our free report on the greatest short-term AI inventory.
READ NEXT: 11 Low PE Excessive Dividend Shares to Purchase In accordance with Analysts and 12 Dependable Dividend Shares for Most Revenue.
Disclosure: None.
[ad_2]
